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Abstract 17 
Haemonchus contortus is the leading parasitic nematode species used to study anthelmintic 18 
drug resistance. A variety of candidate loci have been implicated as being associated with ivermectin 19 
resistance in this parasite but definitive evidence of their importance is still lacking. We have 20 
previously performed two independent serial backcross experiments to introgress ivermectin resistance 21 
loci from two H. contortus ivermectin-resistant strains - MHco4(WRS) and MHco10(CAVR) - into the 22 
genetic background of the ivermectin-susceptible genome reference strain MHco3(ISE). We have 23 
interrogated a number of candidate ivermectin resistance loci in the resulting backcross populations and 24 
assessed the evidence for their genetic linkage to an ivermectin resistance locus. These include the 25 
microsatellite marker Hcms8a20 and six candidate genes Hco-glc-5, Hco-avr-14, Hco-lgc-37 26 
(previously designated Hco-hg-1), Hco-pgp-9 (previously designated Hco-pgp-1), Hco-pgp-2 and Hco-27 
dyf-7. We have sampled the haplotype diversity of amplicon markers within, or adjacent to, each of 28 
these loci in the parental strains and fourth generation backcross populations to assess the evidence for 29 
haplotype introgression from the resistant parental strain into the genomic background of the 30 
susceptible parental strain in each backcross. The microsatellite Hcms8a20 locus showed strong 31 
evidence of such introgression in both independent backcrosses, suggesting it is linked to an important 32 
ivermectin resistance mutation in both the MHco4(WRS) and MHco10(CAVR) strains. In contrast, 33 
Hco-glc-5, Hco-avr-14, Hco-pgp-9 and Hco-dyf-7 showed no evidence of introgression in either 34 
backcross. Hco-lgc-37 and Hco-pgp-2 showed only weak evidence of introgression in the MHco3/4 35 
backcross but not in the MHco3/10 backcross. Overall, these results suggest that microsatellite marker 36 
Hcms8a20, but not the other candidate genes tested, is linked to a major ivermectin resistance locus in 37 
the MHco4(WRS) and MHco10(CAVR) strains. This work also emphasizes the need for genome-wide 38 
approaches to identify mutations responsible for the ivermectin resistance in this parasite.       39 
Keywords: Haemonchus contortus; Nematode; Ivermectin; Anthelmintic; Drug resistance  40 
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1. Introduction 41 
Identifying genetic markers of anthelmintic resistance is a key research priority in order to 42 
provide tools to monitor and manage its emergence and spread (James et al., 2009; Beech et al., 2011). 43 
Anthelmintic resistance is widespread in Haemonchus contortus, a parasitic nematode of small 44 
ruminants that has been a leading model for the study of resistance to ivermectin, one of the most 45 
important drugs used in human and animal helminth control (Kaplan and Vidyashankar, 2012; Gilleard, 46 
2013). There have been many efforts over the last two decades to test specific candidate genes for 47 
associations with ivermectin resistance in H. contortus (Gilleard, 2013). These candidate genes have 48 
been chosen largely on the basis of having potential roles as drug targets or in drug efflux (Gilleard, 49 
2006; Gilleard and Beech, 2007). Although evidence of selection by ivermectin treatment has been 50 
suggested for a number of such loci, their roles in resistance have not yet been conclusively 51 
demonstrated (Gilleard, 2006; Gilleard and Beech, 2007). 52 
In the study presented here, we examine seven genetic loci previously suggested to be 53 
associated with ivermectin resistance in H. contortus; a microsatellite marker Hcms8a20 and six 54 
candidate genes, Hco-avr-14, Hco-glc-5, Hco-lgc-37, Hco-pgp-9, Hco-pgp-2 and Hco-dyf-7. For each 55 
of these loci, we have investigated evidence for genetic linkage to a major ivermectin resistance locus 56 
in two ivermectin-resistant strains, MHco4(WRS) and MHco10(CAVR). These strains are commonly 57 
used in resistance studies and were originally derived as field populations from different continents 58 
(Redman et al., 2008). We have used two previously characterised ivermectin-resistant H. contortus 59 
populations - MHco3/4.BC and MHco3/10.BC - that were independently derived by serial 60 
backcrossing of the MHco4(WRS) and MHco10(CAVR) resistant strains against the MHco3(ISE) 61 
susceptible strain, respectively (Redman et al., 2012). For each of the candidate loci, we evaluated the 62 
evidence for introgression of haplotypes from the resistant parental strains into the fourth generation 63 
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backcross populations in order to determine whether they are located in a region of the genome linked 64 
to a major ivermectin resistance locus (Redman et al., 2012). 65 
The basis on which each of the candidate loci have been previously implicated in ivermectin 66 
resistance is briefly explained here. The Hcms8a20 microsatellite was the only one out of 18 67 
microsatellite loci that showed evidence of genetic introgression in the two independent backcross 68 
experiments undertaken to map ivermectin resistance loci in the MHco4(WRS) and MHco10(CAVR) 69 
strains [strains?] (Redman et al 2012). Hco-avr-14 and Hco-glc-5 are members of the H. contortus 70 
glutamate-gated chloride channel (GLC) family (Wolstenholme and Rogers, 2005; McCavera et al., 71 
2007; Laing et al., 2013). Three members of this family in Caenorhabditis elegans - Cel-glc-1, Cel-72 
avr-14 and Cel-avr-15 - have been shown to be ivermectin targets by genetic mutation and 73 
complementation studies (Dent et al., 2000; Ghosh et al., 2012). The H. contortus homologue of Cel-74 
avr-14 - Hco-avr-14 - was implicated in ivermectin resistance by its ability to rescue ivermectin 75 
susceptibility when heterologously expressed in C. elegans, suggesting it is an ivermectin target in the 76 
parasite (McCavera et al., 2007, 2009; Glendinning et al., 2011). Hco-glc-5 was implicated by the 77 
observation of haplotype frequency changes during experimental passage of an H. contortus strain 78 
under ivermectin selection (Blackhall et al., 1998a). Hco-lgc-37 - a gamma aminobutyric acid 79 
(GABA)-gated chloride channel renamed from Hco-hg-1 (Beech et al., 2010a) - was also implicated 80 
using the same approach and strains (Blackhall et al., 2003). A subsequent study has also presented 81 
evidence that certain alleles of both Hco-glc-5 and Hco-lgc-37 were associated with reduced sensitivity 82 
of adult feeding and larval movement to moxidectin (Beech et al., 2010b).   83 
Hco-pgp-9 and Hco-pgp-2 are members of the P-glycoprotein (PGP) trans-membrane 84 
transporter family. Hco-pgp-9 and Hco-pgp-2 were originally designated as Hco-pgp-1 and Hco-pgp-A, 85 
respectively (Xu et al., 1998; Le Jambre et al., 1999), but were subsequently re-named based on the 86 
identification of their respective C. elegans orthologues (Williamson and Wolstenholme, 2012). This 87 
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gene family, known to be involved in ivermectin efflux in mammals (Schinkel, 1999), has been 88 
suggested to be involved in ivermectin resistance in parasitic nematodes in a number of studies and 89 
reviews (Blackhall et al., 1998b; Xu et al., 1998; Le Jambre et al., 1999, Sangster et al., 1999; Bartley 90 
et al., 2009; Williamson and Wolstenholme, 2012). In the case of Hco-pgp-2, Blackhall et al. (1998b) 91 
used the same methodology and strains as used for Hco-glc-5 and Hco-lgc-37. As with the two 92 
previously examined candidate genes, they showed that a single Hco-pgp-2 haplotype had a 93 
significantly higher frequency in the ivermectin selected population compared with the non-selected 94 
population (Blackhall et al., 1998b). Hco-pgp-9 was independently implicated in ivermectin resistance 95 
by the observation that populations of H. contortus/Haemonchus placei hybrid F1 progeny that 96 
survived ivermectin treatment contained a higher frequency of Hco-pgp-9 alleles derived from the 97 
resistant H. contortus parental strain than from the susceptible H. placei parental strain (Le Jambre et 98 
al., 1999).   99 
The most recent candidate gene to be implicated in ivermectin resistance is Hco-dyf-7, a gene 100 
which encodes a protein required for proper dendritic anchoring and migration of amphid neurons 101 
(Heiman and Shaham, 2009). This gene has recently been proposed to have an important, and possibly 102 
global, role in ivermectin resistance (Urdaneta-Marquez et al., 2014). Classical genetic mapping and 103 
transgenic rescue experiments showed that loss-of-function of the Cel-dyf-7 gene confers ivermectin 104 
resistance in C. elegans (Urdaneta-Marquez et al., 2014). In the same study, an orthologue of this C. 105 
elegans gene was identified in H. contortus, Hco-dyf-7. A specific haplotype of this H. contortus gene, 106 
defined by 15 single nucleotide polymorphisms (SNP)s, was shown to increase in frequency during 107 
ivermectin selection using the same parasite strains as had been previously used by Blackhall et al. 108 
(1998a, 1998b, 2003) for Hco-glc-5, Hco-lgc-37 and Hco-pgp-2. In addition, several - although not all - 109 
of the SNPs that defined this haplotype were reported to occur more frequently in a panel of 110 
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ivermectin-resistant H. contortus field populations compared with several susceptible populations 111 
(Urdaneta-Marquez et al., 2014). 112 
In summary, there is circumstantial, but not conclusive, evidence for the potential association of 113 
a number of different H. contortus candidate loci with ivermectin resistance. In this paper, we 114 
interrogate two previously validated independent backcross experiments for evidence of genetic 115 
linkage of each of these candidate loci to a major ivermectin resistance mutation. Our results support 116 
previous evidence that the microsatellite marker Hcms8a20 is linked to a major invermectin resistance 117 
locus in the two ivermectin-resistant parental strains used in each backcross. In contrast, our results do 118 
not provide similar support for any of the other candidate loci tested. 119 
  120 
2. Materials and methods 121 
2.1. Parasite populations and preparation of genomic DNA  122 
The backcross populations used in this study were derived from two independent backcross 123 
experiments between the susceptible genome reference strain - MHco3(ISE) (Laing et al., 2013) - and 124 
each of two independent ivermectin-resistant strains, MHco4(WRS) and MHco10(CAVR) (Redman et 125 
al., 2012). The MHco3(ISE) strain is susceptible to all the major anthelmintic classes and was 126 
originally derived from the ISE strain by multiple rounds of inbreeding before the genome project was 127 
commenced (Roos et al., 2004; Laing et al., 2013). MHco4(WRS) is derived from the White River 128 
Strain (WRS) originally isolated as an ivermectin-resistant field strain from South Africa (Van Wyk 129 
and Malan, 1988). MHco10(CAVR) is derived from the Chiswick Avermectin Resistant Strain 130 
(CAVR) strain originally isolated as an avermectin-resistant strain from the field in Australia (Le 131 
Jambre et al., 1995). Details of the genetic backcrossing strategy have been previously reported in 132 
Redman et al. (2012), so only a brief overview is given here. F1 progeny of parental crosses were 133 
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exposed to ivermectin by oral dosing and the survivors were then backcrossed against the susceptible 134 
MHco3(ISE) parental strain. Subsequent backcrossing of drug survivors was repeated for three more 135 
generations such that phenotypically resistant fourth generation backcross populations were obtained 136 
(MHco3/4.BC and MHco3/10.BC). These populations have an overall genetic background of the 137 
susceptible parental MHco3(ISE) strain as previously validated with microsatellite markers. However, 138 
they are phenotypically resistant to ivermectin, showing that ivermectin resistance loci have been 139 
introgressed from the original resistant parental strains (Redman et al., 2012). There was no evidence of 140 
sex linkage of the resistance trait from the backcrossing experiments. Pools of genomic DNA were 141 
created by combining lysates from the heads of 20 males and 20 females from each of the three 142 
parental populations - MHco3(ISE), MHco4(WRS) and MHco10(CAVR). The DNA lysis protocol has 143 
been previously described (Redman et al., 2008). The fourth generation backcrosses were 144 
experimentally passaged for one generation to increase worm numbers (Redman et al., 2012). Progeny 145 
of this passage (F2s of the fourth generation backcrosses) were selected with 0.1 mg/kg of ivermectin 146 
in vivo in a controlled efficacy test (Redman et al., 2012) from which drug surviving females were used 147 
to create lysate pools of the MHco3/4.BC and MHco3/10.BC backcrosses assessed in this study. Pools 148 
were created by combining genomic DNA (gDNA) of 33 and 26 drug surviving females of the 149 
MHco3/4.BC and MHco3/10.BC strains, respectively.   150 
 151 
2.2. PCR amplification 152 
 Test PCR amplifications were carried out on the six candidate genes using primer pairs reported 153 
in previously published studies (Blackhall et al. 1998a, b, 2003; Jagannathan et al., 1999; Le Jambre et 154 
al., 1999; Urdaneta-Marquez et al., 2014). Only the Hco-lgc-37 primer pair from Blackhall et al. (2003) 155 
amplified sufficiently robustly in all five populations and were used in this study. Geneious Pro version 156 
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6.1.6 was used to design new primer pairs for the other loci (http://www.geneious.com, Kearse et al., 157 
2012) (Supplementary Table S1). These spanned at least one intron to ensure sufficient polymorphism 158 
was obtained in the amplified sequence. Primers were also designed to amplify a non-coding 725 bp 159 
fragment 1032 bases away from Hcms8a20, a microsatellite for which there was previous evidence of 160 
genetic linkage to an ivermectin resistance locus (Redman et al., 2012). PCRs were performed in 50 µl 161 
reactions using 0.5 μL of pooled gDNA template and Phusion High-Fidelity HF DNA Polymerase 162 
(New England Biolabs, USA country). The following thermocycling conditions were used: 98ºC for 2 163 
min, (98ºC for 10 s, 60ºC for 30 s and 72ºC for 30 s) for 35 cycles, 72ºC for 5 min.  164 
 165 
2.3. Cloning and sequencing of PCR amplicons  166 
PCR products were gel purified using an e.Z.N.A MicroElute® Gel Extraction Kit (Omega 167 
Biotek, USAcountry) and then cloned into the pJET1.2/blunt cloning vector using a CloneJET PCR 168 
Cloning Kit (ThermoFisher Scientific, USAcountry). For each cloning plate, corresponding to each 169 
population/locus combination, 24 colonies were randomly selected and plasmid DNA purified using 170 
the e.Z.N.A Plasmid Mini-Kit I (Omega Biotek) (20 colonies were selected in the case of Hco-dyf-7). 171 
Plasmid clones were then sequenced using the T7(5’-TAATACGACTCACTATAGGG-3’) forward 172 
primer on a BigDye Terminator Cycle Sequencing platform (Applied Biosystems, USAcountry). Hco-173 
pgp-9 clones required an additional (reverse) primer to sequence given its longer amplicon length 174 
(pJET1.2 reverse primer: 5’-AAGAACATCGATTTTCCATGGCAG-3’).  175 
 176 
2.4. DNA sequence analysis 177 
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 All sequences were aligned using the MUSCLE alignment tool (Edgar, 2004) at default settings 178 
in Geneious Pro v. 6.1.6. Primer sequences were trimmed and the sequences were re-aligned. 179 
Polymorphisms appearing more than once in the sequence data set are expected to be real, whereas 180 
polymorphisms that only occur once are possible artefacts due to polymerase-induced errors (Chaudhry 181 
et al., 2015; Redman et al., 2015). Consequently, we only considered SNPs occurring more than once 182 
in the entire dataset in order to take a conservative approach and ensure only real polymorphisms were 183 
considered. Sequence alignments of both the unedited and edited sequences are presented in 184 
Supplementary Figs. S1, S2.     185 
The frequency of each haplotype was determined at each locus for each population and this is 186 
referred to as the “haplotype profile”. Haplotypes were labelled alphabetically for each locus based on 187 
their rank frequency observed in the MHco3(ISE) population (Figs. 1 – 3). Remaining haplotypes not 188 
observed in MHco3(ISE) were labelled arbitrarily. The number of clones successfully sequenced and 189 
the number of different haplotypes observed at each locus were recorded for each strain (Table 1). For 190 
each locus, the number of haplotypes shared by the parental strains of a cross, together with the number 191 
of haplotypes unique to each parental strain of a cross, was also recorded (Table 1). Pairwise Fst values 192 
(calculated in Arlequin v. 3.1 at default settings; Excoffier et al., 2005) were used to quantify the level 193 
of similarity between haplotype profiles between parental and backcross populations for each amplicon 194 
marker. P-values of less than 0.05 were considered significant. 195 
 196 
2.5. Chromosomal assignments for each amplicon marker  197 
Chromosomal synteny is high between H. contortus and C. elegans (although gene order on a 198 
chromosome is generally poorly conserved) (Laing et al., 2011). Consequently, we inferred the 199 
chromosomal assignment for each amplicon marker based on the syntenic relationships with the C. 200 
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elegans orthologues of gene models present on the same H. contortus genomic scaffold. The closest 14 201 
gene models on the same genome scaffold as each amplicon marker (a total of 15 gene models 202 
including the candidate gene) were assessed for orthology with C. elegans genes where possible. 203 
Scaffolds containing the Hcms8a20 and Hco-lgc-37 amplicon markers were small, so all gene models 204 
on each scaffold were assessed (1 and 6, respectively). A custom BLAST search (Liebert et al., 2000) 205 
(blastn -task dc-megablast -query H.contortus_genes.fa -db C.elegans_CDSs.fa -out outfile) was used 206 
to identify orthologues in the most current ensembl.org C. elegans CDS database downloaded at 207 
ftp://ftp.ensembl.org/pub/release-83/fasta/caenorhabditis_elegans/cds/. Only unambiguous orthologues 208 
were used in the analysis of synteny. Identification of a C. elegans orthologue was considered 209 
unambiguous if the H. contortus query gene model identified a C. elegans gene model with an e-value 210 
of 1e-9 or less and with no other hits on different chromosomes having an e-value within one order of 211 
magnitude. Hco-glc-5, Hco-avr-14 and Hco-pgp-2 are located on chromosome 1, Hco-lgc-37 on 212 
chromosome 3, and Hco-dyf-7 on the X chromosome (Supplementary Table S2). A chromosomal 213 
assignment could not be made for Hco-pgp-9 due to mixed chromosomal synteny with C. elegans 214 
orthologues, nor for Hcms8a20 due to the lack of adjacent gene models on the relatively short scaffold 215 
on which it was located (27 kb).     216 
[Somewhere in section 2 mention which P value was considered significant because you 217 
mention P values in section 3.] 218 
3. Results 219 
3.1. Amplicon markers for all the candidate loci show a high level of genetic differentiation between 220 
the H. contortus parental strains used in the two independent backcross experiments  221 
In order to investigate haplotype introgression between parental genomes during a serial 222 
backcross, markers with a high level of genetic differentiation between parental strains are needed. In 223 
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this particular case, haplotypes unique to the ivermectin-resistant parental strain, or those present at 224 
very different frequencies in the two parental strains, are the most informative for assessing haplotype 225 
introgression from each resistant parental strain into the backcross populations. Consequently, we first 226 
assessed the haplotype diversity of the seven amplicon markers within and among the parental strains 227 
used in the two backcrosses. We PCR-amplified and sequenced between 14 and 24 clones for each 228 
marker from the MHco3(ISE), MHco4(WRS) and MHco10(CAVR) parental strains (Table 1). A high 229 
level of sequence diversity was observed for all seven loci (Table 1). The mean number of haplotypes 230 
for the seven markers was 3.5, 8.33 and 5.83 haplotypes per locus for MHco3(ISE), MHco4(WRS) and 231 
MHco10(CAVR) parental strains, respectively (Table 1).       232 
Although some shared haplotypes were present, the majority were not shared between the 233 
parental strains used in each backcross (Table 1). Pairwise Fst values were used to quantify the genetic 234 
differentiation for each amplicon marker between the parental strains (Table 2). There was a high level 235 
of genetic differentiation between the MHco3(ISE) susceptible parental strain and both resistant 236 
parental strains, MHco4(WRS) and MHco10(CAVR), for all seven amplicon markers. Pairwise Fst 237 
values ranged between 0.078 and 0.533 and all were statistically significantly different from zero at P 238 
<0.01 (Table 2). 239 
 240 
3.2. The amplicon marker adjacent to microsatellite Hmcs8a20 shows strong evidence of haplotype 241 
introgression from the ivermectin-resistant parental strain in both independent backcross populations 242 
We investigated the evidence for haplotype introgression from the resistant parental strains into 243 
the two independent backcross populations for an amplicon marker adjacent to microsatellite 244 
Hmcs8a20. This marker was PCR-amplified, cloned and sequenced from the MHco3/4.BC and 245 
MHco3/10.BC backcross populations and the haplotype profiles compared with those of the parental 246 
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strains (Table 1). In both of these backcross populations, this marker showed a high degree of genetic 247 
differentiation from the MHco3(ISE) susceptible parental strain; Fst values were high and statistically 248 
significantly different from zero for both the MHco3(ISE) - MHco3/4.BC and MHco3(ISE) - 249 
MHco3/10.BC pairwise comparisons (Fst = 0.383, P = 0.000 and Fst = 0.512, P = 0.000, respectively) 250 
(Table 3). The most frequent haplotypes of this marker in the two backcross populations were 251 
haplotype-D in MHco3/4.BC and haplotype-E in MHco3/10.BC at 60.9% and 78.3% frequencies, 252 
respectively. These haplotypes were not detected in the MHco3(ISE) susceptible parental isolate but 253 
were present in respective resistant parental strains used in each backcross (Fig. 1). These results 254 
suggest haplotype introgression from each resistant parental strain into the MHco3(ISE) susceptible 255 
parental background during both independent backcrossing experiments.  256 
 257 
3.3. The amplicon markers within the Hco-glc-5, Hco-avr-14, Hco-pgp-9 and Hco-dyf-7 genes show no 258 
evidence of haplotype introgression from the ivermectin-resistant parental strain in either of the 259 
independent backcross populations 260 
Amplicon markers within the Hco-glc-5, Hco-avr-14, Hco-pgp-9 and Hco-dyf-7 genes were 261 
PCR-amplified, cloned and sequenced from the MHco3/4.BC and MHco3/10.BC backcross 262 
populations, and the haplotype profiles compared with those present in the parental strains (Table 1). 263 
We measured the level of pairwise genetic differentiation for each of these markers between the 264 
MHco3(ISE) parental strain and each of the MHco3/4.BC and MHco3/10.BC backcross populations. In 265 
all pairwise comparisons, the Fst values were not statistically significantly different from zero (Table 266 
3). In contrast to the Hcms8a20 amplicon marker, the most frequent haplotype present in each 267 
backcross population was not unique to the resistant parental strain for any of the four candidate 268 
ivermectin resistance loci. Furthermore, in all cases, the most frequent haplotype present in backcross 269 
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populations was present at a higher frequency in the MHco3(ISE) susceptible parental strain than the 270 
resistant parental strain (Figs. 2, 3). These results suggest no evidence of haplotype introgression from 271 
either resistant parental strain into the MHco3(ISE) susceptible parental background during either of 272 
the backcrossing experiments for these four amplicon markers.  273 
 274 
3.4. The amplicon markers within the Hco-lgc-37 and Hco-pgp-2 genes show weak evidence of 275 
haplotype introgression from the ivermectin-resistant parental strain in the MHco3/4.BC backcross but 276 
not the MHco3/10.BC backcross populations 277 
Amplicon markers within the Hco-lgc-37 and Hco-pgp-2 genes were PCR-amplified, cloned 278 
and sequenced from the MHco3/4.BC and MHco3/10.BC backcross populations and the haplotype 279 
profiles compared with those present in the parental strains (Table 1). We measured the level of 280 
pairwise genetic differentiation for each of these markers between the MHco3(ISE) parental strain and 281 
each of the MHco3/4.BC and MHco3/10.BC backcross populations. In the case of the MHco3/10.BC 282 
backcross, the Fst values were not statistically significantly different from zero for either marker (Table 283 
3). For the MHco3/4.BC backcross, the MHco3(ISE)-MHco3/4.BC pairwise Fst values were 284 
statistically significantly different from zero for both the Hco-lgc-37 and Hco-pgp-2 markers at 0.220 285 
(P = 0.004) and 0.115 (P = 0.000), respectively (Table 3). For these two pairwise comparisons, there 286 
was also a haplotype present in the backcross populations that was unique to the resistant parental 287 
strain with respect to the MHco3(ISE) parental strain; haplotype-I of Hco-pgp-2 and haplotype-H of 288 
Hco-lgc-37 (Fig. 2). However, these were only present at very low frequencies in each backcross (Fig. 289 
2). These results provide weak evidence for haplotype introgression from the resistant parental strains 290 
into the MHco3(ISE) susceptible parental background for these two markers in the MHco3/4.BC 291 
backcross but not in the MHco3/10.BC backcross populations. 292 
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 293 
4. Discussion 294 
The objective of this work was to investigate a number of leading candidate loci for evidence of 295 
genetic linkage to a major ivermectin resistance locus in two ivermectin-resistant H. contortus strains; 296 
MHco4(WRS) and MHco10(CAVR). These two strains have previously been serially backcrossed 297 
against the ivermectin-susceptible H. contortus genome reference strain MHco3(ISE) with ivermectin 298 
selection applied at each generation (Redman et al., 2012). The resulting fourth generation backcross 299 
populations (MHco3/4.BC and MHco3/10.BC) have been previously genetically and phenotypically 300 
validated (Redman et al., 2012). In that study, 17 out of 18 microsatellite markers were found to have 301 
allelic profiles in the MHco3/4.BC and MHco3/10.BC populations that were similar to those of the 302 
MHco3(ISE) susceptible parental strain. This demonstrated that the genetic background of these 303 
backcross populations was predominantly derived from the MHco3(ISE) susceptible parental strain as 304 
expected from the serial backcrossing regime. In the original published study, just one of the 18 305 
microsatellite markers, Hcms8a20, had an allele at high frequency in the backcross populations 306 
(following ivermectin treatment) that was derived from the resistant parental strains in both serial 307 
backcross experiments (Redman et al., 2012). This result suggested that this microsatellite marker is 308 
linked to an important ivermectin resistance locus in both the MHco4(WRS) and MHco10(CAVR) 309 
ivermectin-resistant strains.  310 
In the work presented here, we aimed to test the hypothesis that the Hcms8a20 microsatellite 311 
marker was linked to an important ivermectin-resistant locus in the MHoc4(WRS) and 312 
MHco10(CAVR) strains and, at the same time, test the other leading candidate ivermectin resistance 313 
loci from the peer-reviewed literature. Fig. 4 illustrates the conceptual approach we adopted. We 314 
examined the haplotype profiles of PCR amplicon markers located within, or close to, our loci of 315 
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interest in the parental and backcross populations of both serial backcross experiments. If a genetic 316 
marker is closely linked to an important ivermectin resistance locus, haplotypes of that marker that are 317 
present in the ivermectin-resistant parental strain, and linked to the ivermectin resistance mutation, 318 
should be inherited through the backcross due to the ivermectin selection applied at each generation by 319 
so called “genetic hitchhiking” (Fig. 4A). Consequently, such haplotypes will be introgressed from the 320 
ivermectin-resistant parental strain into the predominantly MHco3(ISE) genetic background during the 321 
backcrossing procedure (Fig. 4A). Hence, it is possible to make predictions regarding the haplotype 322 
profiles of markers in the backcross populations depending on whether or not they are linked to an 323 
important ivermectin resistance mutation (Fig. 4B). The presence and frequency of haplotypes for a 324 
marker that is not linked to an important ivermectin resistance locus should be very similar to those 325 
found in the MHco3(ISE) parental strain and haplotypes that are unique to the resistant parental strain 326 
should be absent (or rare) in the backcross populations. This is because there will be no introgression of 327 
haplotypes from the ivermectin-resistant parental strain into the backcross populations in that region of 328 
the genome (markers A and C in Fig. 4). Conversely, the presence and frequency of haplotypes for a 329 
marker that is linked to an important ivermectin resistance locus should differ significantly from those 330 
in the MHco3(ISE) parental strain due to the presence of one or more haplotypes that have been 331 
introgressed from the resistant parental strain (markers B and D in Fig. 4). The extent of this difference 332 
will depend on how closely linked the marker is to the loci under selection. 333 
The haplotype profiles of the amplicon marker located 17.8 kb away from the Hcms8a20 334 
microsatellite marker locus clearly fit the predictions for a marker linked to an important ivermectin 335 
resistance locus. In both the MHco3/4.BC and MHco3/10.BC backcross populations, the haplotype 336 
profiles of the Hcms8a20 amplicon marker were significantly different to the haplotype profile that was 337 
present in the MHco3(ISE) susceptible reference strain (Table 3, Fig. 1). This is indicated by the high 338 
Fst values observed between both backcross populations and the MHco3(ISE) strain, by far the highest 339 
16 
 
values for any of the seven loci examined (Table 3). Furthermore, in both backcross populations the 340 
most frequent haplotype for the Hcms8a20 amplicon marker was one which was present in each 341 
ivermectin-resistant parental strain but absent from the MHco3(ISE) susceptible parental strain; 342 
haplotype-D in MHco3/4.BC and haplotype-E in MHco3/10.BC (Fig. 1). This suggests that these 343 
haplotypes have been inherited from the resistant parental strains during the serial backcrosses under 344 
the influence of the ivermectin selection applied at each generation. Interestingly, a different haplotype 345 
has been introgressed from each resistant parental strain in the two independent backcross experiments. 346 
This is consistent with the previously published results using the allele profiles of the Hcms8a20 347 
microsatellite marker itself (Redman et al., 2012). In that case, for each separate backcross experiment, 348 
a different microsatellite allele, specific to each ivermectin-resistant parental strain, was introgressed 349 
into the backcross populations. This is not necessarily surprising since MHco4(WRS) and 350 
MHco10(CAVR) were originally derived from different continents - South Africa and Australia, 351 
respectively - so the causal ivermectin resistance mutation(s) may well have originated independently 352 
in the two strains. In that case, they would be expected to be present on different haplotype 353 
backgrounds in each strain.  354 
In contrast to the Hcms8a20 marker, the haplotype profiles of the amplicon markers within the 355 
candidate ivermectin resistance genes Hco-glc-5, Hco-avr-14, Hco-pgp-9 and Hco-dyf-7 clearly fit the 356 
predictions for markers that are not linked to an important ivermectin resistance locus in the 357 
MHco4(WRS) and MHco10(CAVR) resistant strains. For these markers, there was no significant 358 
difference in the haplotypes present in either of the independent backcross populations compared with 359 
the susceptible MHco3(ISE) population. Furthermore, unlike for the Hcms8a20 amplicon marker, there 360 
were no haplotypes unique to either resistant parental strain present in either of the backcross 361 
populations for any of these genes. This was also the case for the amplicon markers within the Hco-lgc-362 
37 and Hco-pgp-2 genes for the MHco3/10.BC backcross population, suggesting these genes are also 363 
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not linked to an important ivermectin resistance locus in the MHco10(CAVR) strain. However, the 364 
result for these two markers was less clear cut in the other backcross experiment; there was a 365 
statistically significant difference in the haplotypes present in the MHco3/4.BC backcross population 366 
compared with the susceptible MHco3(ISE) population. Also, for each of these two markers, there was 367 
a haplotype present in the MHco3/4.BC backcross population that was unique to the MHco4(WRS) 368 
resistant parental strain (haplotype-I for Hco-pgp-2 and haplotype-H for Hco-lgc-37). However, these 369 
haplotypes were present at very low frequencies in the MHco3/4.BC population. Overall, we conclude 370 
there is weak but inconclusive evidence of linkage of the Hco-lgc-37 and Hco-pgp-2 genes to an 371 
important ivermectin resistance locus in the MHco4(WRS), but not the MHco10(CAVR), strain. This 372 
more ambiguous result could potentially be due to these genes being distantly linked to an important 373 
ivermectin resistance locus on the same chromosome or tightly linked to a locus with a minor effect.   374 
Although the results presented here provide additional evidence that the Hcms8a20 marker is 375 
genetically linked to an important ivermectin resistance locus in the MHco4(WRS) and 376 
MHco10(CAVR) strains, this is not the case for the other leading candidate ivermectin resistance loci. 377 
It is possible that these loci are not associated with ivermectin resistance given they have been 378 
implicated largely on the basis of single studies using a small number of populations and often a small 379 
number of individuals within each population. Other recent work has also found no evidence of 380 
selection for the Hco-lgc-37, Hco-glc-5, Hco-avr-14 and Hco-dyf-7 loci when comparing H. contortus 381 
from UK farms with a history of ivermectin treatment with those without (Laing R, Maitland K, 382 
Lecová L, Skuce P, Tait A, Devaney E;, In press [either ‘in press’ or ‘unpublished data’]). 383 
Alternatively, it may be that these loci are linked to an important ivermectin loci in some strains but not 384 
in MHco4(WRS) and MHco10(CAVR). This is possible since the previous published work implicating 385 
these candidate loci was not conducted on these particular strains.  386 
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Although this and previous work provides strong evidence that the Hcms8a20 microsatellite 387 
marker is genetically linked to an important ivermectin resistance locus in the MHco4(WRS) and 388 
MHco10(CAVR) strains, it could be still be relatively distant from the causal mutation(s). Only limited 389 
genetic recombination will have occurred in four generations of backcrossing. Consequently, the 390 
genomic region(s) introgressed into the backcross populations from the resistant parental strains is 391 
expected to be large. This is supported by recent genome-wide SNP analysis of the backcross and 392 
parental populations that has identified several genomic scaffolds that have a strong signal of 393 
introgression, some of which are several Mb in length (Martinelli, A, Rezansoff, A, Doyle, S, Gilleard, 394 
J and Cotton, J, unpublished data). The Hcms8a20 marker is located on one of these scaffolds, 395 
providing further support for its linkage to an important ivermectin resistance locus (Martinelli, A, 396 
Rezansoff, A, Doyle, S, Gilleard, J and Cotton, J, unpublished data). Further interrogation of the H. 397 
contortus MHco3(ISE) reference genome as the assembly improves will help locate the genomic 398 
position of the causal mutations to which the Hcms8a20 locus is linked (http://www.sanger.ac.uk/ 399 
resources/downloads/helminths/haemonchus-contortus.html). 400 
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Figure Legends 532 
[Each figure legend must ‘stand alone’, separate from every other figure legend and the main text.  533 
Therefore if the information provided in the figure legend is specific to a particular parasite 534 
genus/species, the genus/species should be mentioned in the first summary sentence of the figure 535 
legend.] 536 
 537 
Fig. 1. Frequency histograms of haplotypes of the amplicon marker adjacent to microsatellite 538 
Hcms8a20. Haplotypes are labelled alphabetically on the X axis with respective frequencies observed 539 
on the Y axis in each population. (A) Haplotype distributions for the MHco4(WRS) x MHco3(ISE) 540 
backcross by frequency histograms for MHco3(ISE), MHco4(WRS) and MHco3/4.BC, respectively. 541 
(B) Haplotype distributions for the MHco10(CAVR) x MHco3(ISE) backcross by frequency 542 
histograms for MHco3(ISE), MHco10(CAVR) and MHco3/10.BC, respectively. 543 
 544 
Fig. 2. Haplotype distributions for the candidate loci in the MHco4(WRS) x MHco3(ISE) backcross. 545 
Frequency histograms of haplotypes of the six candidate gene loci assessed in this study are shown for 546 
the MHco3(ISE), MHco4(WRS) and MHco3/4.BC backcross strains. Haplotypes are labelled 547 
alphabetically on the X axis with respective frequencies observed on the Y axis in each population.  548 
 549 
Fig. 3. Haplotype distributions for the candidate loci in the MHco10(CAVR) x MHco3(ISE) backcross. 550 
Frequency histograms of haplotypes of the six candidate gene loci assessed in this study are shown for 551 
the MHco3(ISE), MHco10(CAVR) and MHco3/10.BC backcross strains. Haplotypes are labelled 552 
alphabetically on the X axis with respective frequencies observed on the Y axis in each population.  553 
 554 
Fig. 4. [?general heading] (A) Schematic representation of the genomes of the resistant and susceptible 555 
parental strains and the backcross population. The coloured bars represent the five pairs of 556 
chromosomes with the resistant parental strain genetic background represented in red and the 557 
susceptible parental genetic background represented in blue. Causal resistance mutations are indicated 558 
by *. The positions of four hypothetical genetic markers A, B, C and D are indicated. (B) Predictions 559 
for the haplotype profiles of the four hypothetical genetic markers in the backcross population. 560 
 561 
 562 
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 564 
[For both supplementary figures, given the larges amounts of data (Alex Loukas has approved this 565 
requested change), please consider submitting the data to Mendeley and replace all references to the 566 
figures in the manuscript with the relevant urls supplied by Mendeley.  See https://data.mendeley.com/] 567 
 568 
Supplementary Fig. S1. Sequence alignments for each of the seven loci using unedited sequences (no 569 
singleton single nucleotide polymorphisms (SNPs) removed).    570 
 571 
Supplementary Fig. S2. Sequence alignments for each of the seven loci using edited sequences 572 
(singleton single nucleotide polymorphisms (SNPs) removed).    573 
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Table 1. Summary of the results of sequencing data for cloned PCR products for each candidate locus from each of the Haemonchus 
contortus parental and backcross strains.   
 
 
 
 
  Strain Hcms8a20 Hco-glc-5 Hco-avr-14 Hco-lgc-37 Hco-pgp-9 Hco-pgp-2 Hco-dyf-7 Mean  
Number of clones sequenced MHco3(ISE) 21 23 23 24 24 22 16 22.00 
MHco4(WRS) 22 24 21 24 24 13 13 19.83 
MHco3/4.BC 23 21 22 24 23 18 16 20.67 
MHco10(CAVR) 24 23 21 23 23 17 16 20.50 
MHco3/10.BC 23 23 22 24 23 22 14 21.33 
          
Number of distinct haplotypes 
observed in each strain 
MHco3(ISE) 3 3 5 4 5 3 1 3.50 
MHco4(WRS) 4 9 8 9 13 5 6 8.33 
MHco3/4.BC 3 1 4 4 3 5 2 3.17 
MHco10(CAVR) 5 6 6 6 9 5 3 5.83 
MHco3/10.BC 4 4 3 7 7 2 3 4.33 
Total no. of distinct haplotypes 9 16 17 18 25 10 10 16.00 
          
Shared vs. unique haplotypes 
for MHco3(ISE) and 
MHco4(WRS) parental strains 
Shared  1 2 1 2 2 2 1 1.67 
Unique to MHco3(ISE) 2 1 4 2 3 1 0 1.83 
Unique to MHco4(WRS) 3 7 7 7 11 3 5 6.67 
          
Shared vs. unique haplotypes 
for  MHco3(ISE) and 
MHco10(CAVR) parental strains 
Shared  0 2 1 1 3 1 1 1.50 
Unique to MHco3(ISE) 3 1 4 3 2 2 0 2.00 
Unique to MHco10(CAVR) 5 4 5 5 6 4 2 4.33 
 Table 2. Pairwise Fst values between the susceptible Haemonchus contortus MHco3(ISE) parental strain and MHco4(WRS) and 
MHco10(CAVR) resistant parental strains. Associated P values are shown in parentheses.  
 
 
a P < 0.05 was considered statistically significant. 
 
 
 
 
  
Pairwise Comparison Hcms8a20 Hco-glc-5 Hco-avr-14 Hco-lgc-37 Hco-pgp-9 Hco-pgp-2 Hco-dyf-7 
MHco3(ISE)-MHco4(WRS) 0.382 (0.000) a 0.340 (0.000) a 0.120 (0.000) a 0.078 (0.009) a 0.163 (0.000) a 0.281 (0.000) a 0.484 (0.000) a 
MHco3(ISE)-MHco10(CAVR) 0.358 (0.000) a 0.533 (0.000) a 0.166 (0.000) a 0.108 (0.000) a 0.140 (0.000) a 0.253 (0.000) a 0.367 (0.002) a 
Table 3. Pairwise Fst values between the susceptible Haemonchus contortus MHco3(ISE) parental strain and MHco3/4.BC and 
MHco3/10.BC backcross strains. Associated P values are shown in parentheses.  
 
 
a P < 0.05 was considered statistically significant. 
 
Pairwise Comparison Hcms8a20 Hco-glc-5 Hco-avr-14 Hco-lgc-37 Hco-pgp-9 Hco-pgp-2 Hco-dyf-7 
MHco3(ISE)-MHco3/4.BC 0.383 (0.000) a 0.095 (0.063) 0.000 (0.676) 0.115 (0.000) a 0.055 (0.135) 0.220 (0.004) a 0.000 (0.999) 
MHco3(ISE)-MHco3/10.BC 0.512 (0.000) a 0.000 (0.514) 0.003 (0.225) 0.000 (0.450) 0.025 (0.153) 0.014 (0.371) 0.117 (0.108) 
Supplementary Table S1. Forward and reverse primers and the PCR product length for each amplicon marker are shown. The length 
of each genome scaffold on which each amplicon marker is located in the most recent version of the Haemonchus contortus 
MHco3(ISE) genome assembly (as of June 2014; made available by James Cotton and Matt Berriman of the Wellcome Trust Sanger 
Institute (WTSI), UK  is indicated.  
 
 
 
 
  
Locus Amplicon length (bp) Forward primer (5'-3') - Exon Reverse primer (5'-3') - Exon Size of scaffold (kbp) 
Hcms8a20 725 GAAGCGGCTCAGATGATAAAGG -not exonic TTACCGAGGGACTCCGAATG - not exonic 27 
Hco-glc-5 420 CCGGCTCGGGTTACGCT - exon 5 CTTGTCGTGAGTCTGGATTC - exon 3 14,479 
Hco-avr-14 490 TCGTAGTGTTGGCGACCAG - exon 10 CAACGGGTAGAACTCCAATG - exon 8 6,538 
Hco-lgc-37 270 GGTGATGTCATGGGTGTC - exon 7 TTGCTGCGAATACGAATC - exon 9 94 
Hco-pgp-1 790 AAGTACCATAATCCAGTTGTTAC - exon 11 CAGCAAGAGAATTTTCGGATC - exon 14 6,023 
Hco-pgp-2 450 ACCTACGCTGTTGCCGGTGC - exon 7 GTGCCGAGAGCTGCTGAGCC - exon 10 12,643 
Hco-dyf-7 690 TCTTTCCAGTGGACGAGGTGTCA - exon 8 AGAGGTCGTCCATCAGTGCTTCT - exon 5 11,346 
 Supplementary Table S2. Chromosomal assignment (in bold) of Caenorhabditis elegans orthologues of the gene models adjacent to 
each candidate Haemonchus contortus (Hco) gene on their respective genome assembly scaffolds. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Chromosome Hco-glc-5 Hco-avr-14 Hco-lgc-37 Hco-pgp-9 Hco-pgp-2 Hco-dyf-7 
I 5 12 0 1 6 0 
II 0 0 0 0 0 0 
III 0 0 3 3 0 0 
IV 0 0 0 4 0 0 
V 0 0 0 2 0 0 
X 0 0 0 0 0 10 
No homology 10 3 3 5 9 5 
Total 15 15 6 15 15 15 
